30 Results for "

ENPP3

" in MedChemExpress (MCE) Product Catalog:
Products (30)

30 Results for "ENPP3" in MCE Product Catalog:

  • Recombinant Proteins Recommended:
Cat. No.: HY-169804
CAS No.: 2803505-90-8
Research Areas:  

Cancer

ENPP3 Inhibitor 1 is a selective inhibitor of ENPP3, with IC50s of 0.15 µM (ENPP3) and 41.4 µM (ENPP1) respectively. ENPP3 Inhibitor 1 shows anti-tumor activities against breast cancer and cervical cancer .
loading...
    loading...
Cat. No.: HY-P990315
Synonyms: AGS-16C

Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology

Anti-ENPP3/CD203c Antibody (AGS-16C3F antibody) is a humanized antibody expressed in CHO cells, targeting ENPP3/CD203c. Anti-ENPP3/CD203c Antibody contains a huIgG2 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 154.04 kDa. The isotype control for Anti-ENPP3/CD203c Antibody can refer to Human IgG2 kappa, Isotype Control (HY-P99002).
loading...
    loading...
Cat. No.: HY-171544
Synonyms: AGS-16M8F
AGS-16C3F is an antibody-drug conjugate (ADC) targeting ENPP3. AGS-16C3F is composed of ENPP3-targeting Anti-ENPP3/CD203c Antibody (HY-P990315) linked to Monomethyl auristatin F (HY-15579) via a linker. AGS-16C3F has anti-tumor activity and can be used in the study of metastatic renal cell carcinoma (mRCC) .
loading...
    loading...
Cat. No.: HY-158791
CAS No.: 2803505-78-2
Purity:  96.10%
Research Areas:  

Metabolic Disease Cancer

Enpp-1-IN-21 (compound 4g) is an inhibitor of ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), with IC50 values for ENPP1 and ENPP3 at 0.45 and 0.19 μM, respectively .
loading...
    loading...
Cat. No.: HY-RS24067
Research Areas:  

Others

Enpp3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Enpp3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-175478
CAS No.: 3105103-33-8
Enpp-1-IN-27 is a selective ENPP1 inhibitor with an IC50 of 14.68 nM, exhibiting approximately 410-fold selectivity against ENPP2 and 10-fold selectivity against ENPP3. Enpp-1-IN-27 stabilizes cGAMP levels and activates the STING pathway, promoting cytokine release and enhancing innate immune responses. Enpp-1-IN-27 induces ISRE activation and amplified cGAMP-mediated immune responses and shows the desired antitumor efficacy in the 4T1 and CT26 syngeneic mouse models. Enpp-1-IN-27 can used for the studies of breast cancer and colon cancer .
loading...
    loading...
Cat. No.: HY-RS04389
Research Areas:  

Others

ENPP3 Human Pre-designed siRNA Set A contains three designed siRNAs for ENPP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS17607
Research Areas:  

Others

Enpp3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Enpp3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P991706
CAS No.: 3029433-56-2

Research Areas:  

Cancer

Nelvutamig is a humanized immunoglobulin (H-gamma1_L-kappa)_scFvkh-G1(h-CH2-CH3) antibody targeting ENPP3/CD203c and CD3E. The corresponding isotype control is: Human immunoglobulin (H-gamma1_L-kappa)_scFvkh-G1(h-CH2-CH3) .
loading...
    loading...
Cat. No.: HY-P991705
CAS No.: 2911556-99-3
Synonyms: JJP-1212

Target:  

Fc Receptor (FcR)

Research Areas:  

Inflammation/Immunology

Nebaprubart (JJP-1212) is a humanized IgG4κ antibody against FCAR/CD89, and its corresponding isotype control is Human IgG4 kappa, Isotype Control (HY-P99003). Nebaprubart works by blocking a key receptor involved in inflammation .
loading...
    loading...
Cat. No.: HY-172527
Research Areas:  

Cancer

CD73-IN-20 (Compound 5c) is an e5′NT (CD73) inhibitor (IC50: 0.37 μM). CD73-IN-20 also inhibits other ectonucleotidases, with IC50s of 1.12 μM (h-ENPP1), 1.37 μM (h-ENPP3), 1.66 μM (r-e5′NT), 1.48 μM (h-TNAP), respectively. CD73-IN-20 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-172528
Research Areas:  

Cancer

Enpp-1/3-IN-1 (Compound 5j) is an ENPP1/ENPP3 inhibitor, with IC50s of 0.59 μM (h-ENPP1) and 0.62 μM (h-ENPP3) respectively. Enpp-1/3-IN-1 also inhibits e5′NT (CD73) and TNAP with IC50s of 0.89 μM (h-e5′NT), 5.12 μM (r-e5′NT) and 1.68 μM (h-TNAP), respectively. Enpp-1/3-IN-1 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-147998
CAS No.: 2417022-19-4
Research Areas:  

Cancer

Enpp-1-IN-13 (Compound 1a) is an ectonucleotide pyrophosphatase/phosphodiesterase (ENPP) inhibitor with IC50 values of 1.29 μM and 20.2 μM against ENPP1 and ENPP3, respectively. Enpp-1-IN-13 shows anticancer activity .
loading...
    loading...
Cat. No.: HY-P78705
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: ENPP3; CD203c; NPP3; E-NPP3; PD-Ibeta; NPPase; PDNP3
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P704579
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: E-NPP 3; NPP3; PD-Ibeta; NPPase; ENPP3; PDNP3; CD203c; B10; gp130RB13-6
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P700438
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: E-NPP 3; NPP3; PD-Ibeta; NPPase; ENPP3; PDNP3; CD203c; B10; gp130RB13-6
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P705017
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: E-NPP 3; NPP3; PD-Ibeta; NPPase; ENPP3; PDNP3; CD203c; B10; gp130RB13-6
Species:  
Source:  
CHO
loading...
    loading...
Cat. No.: HY-P700410
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: E-NPP 3; NPP3; PD-Ibeta; NPPase; ENPP3; PDNP3; CD203c; B10; gp130RB13-6
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P77925
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: E-NPP 3; NPP3; PD-Ibeta; NPPase; ENPP3; PDNP3; CD203c; B10; gp130RB13-6
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P700710
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: E-NPP 3; NPP3; PD-Ibeta; NPPase; ENPP3; PDNP3; CD203c; B10; gp130RB13-6; PD-Iβ
Species:  
Source:  
loading...
    loading...